Incyte Corp. (INCY)
113.75
+6.22
(+5.78%)
USD |
NASDAQ |
Jun 26, 16:00
113.77
+0.02
(+0.02%)
After-Hours: 20:00
Incyte Cash and Short Term Investments (Quarterly) : 4.016B for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.016B |
| December 31, 2025 | 3.581B |
| September 30, 2025 | 2.930B |
| June 30, 2025 | 2.422B |
| March 31, 2025 | 2.409B |
| December 31, 2024 | 2.158B |
| September 30, 2024 | 1.775B |
| June 30, 2024 | 1.519B |
| March 31, 2024 | 3.851B |
| December 31, 2023 | 3.656B |
| September 30, 2023 | 3.516B |
| June 30, 2023 | 3.423B |
| March 31, 2023 | 3.113B |
| December 31, 2022 | 3.239B |
| September 30, 2022 | 2.977B |
| June 30, 2022 | 2.722B |
| March 31, 2022 | 2.544B |
| December 31, 2021 | 2.348B |
| September 30, 2021 | 2.284B |
| June 30, 2021 | 2.081B |
| March 31, 2021 | 1.962B |
| December 31, 2020 | 1.801B |
| September 30, 2020 | 1.735B |
| June 30, 2020 | 1.589B |
| March 31, 2020 | 1.303B |
| Date | Value |
|---|---|
| December 31, 2019 | 2.118B |
| September 30, 2019 | 1.986B |
| June 30, 2019 | 1.696B |
| March 31, 2019 | 1.581B |
| December 31, 2018 | 1.438B |
| September 30, 2018 | 1.375B |
| June 30, 2018 | 1.198B |
| March 31, 2018 | 1.171B |
| December 31, 2017 | 1.170B |
| September 30, 2017 | 1.281B |
| June 30, 2017 | 608.61M |
| March 31, 2017 | 511.96M |
| December 31, 2016 | 808.56M |
| September 30, 2016 | 716.60M |
| June 30, 2016 | 629.21M |
| March 31, 2016 | 811.19M |
| December 31, 2015 | 708.30M |
| September 30, 2015 | 635.56M |
| June 30, 2015 | 627.99M |
| March 31, 2015 | 585.92M |
| December 31, 2014 | 600.76M |
| September 30, 2014 | 532.86M |
| June 30, 2014 | 509.50M |
| March 31, 2014 | 519.86M |
| December 31, 2013 | 509.50M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 386.26M |
| Eli Lilly & Co. | 5.282B |
| Biogen, Inc. | 4.283B |
| BioMarin Pharmaceutical, Inc. | 2.222B |
| ACADIA Pharmaceuticals, Inc. | 851.46M |